611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Women's Health
Resources
Basic InformationLatest News
Mom's Weight-Loss Surgery Lowers Many Pregnancy Complications, Raises OthersPregnant Women Need to Take Care in Sweltering Summer HeatAre Antibiotics Really the Answer for UTIs in Women?Stronger Hearts, Better Outcomes in Pregnancy: StudyCould Menopausal Hormone Therapy Reduce Women's Odds for Dementia?Screening Often Misses Endometrial Cancer in Black WomenAHA News: Pregnant Mom's Diet May Influence Baby's Cardiovascular HealthPandemic Delays in Screening Mean More Breast Cancer Deaths Ahead: StudyUrinary Incontinence Can Affect a Woman's Mental HealthCOVID Vaccine Doesn't Infiltrate Breast MilkGap in Breast Cancer Survival for Black, White Patients Shrinks, But Not by EnoughCost a Barrier to Cervical Cancer Screening for Many U.S. WomenAlcohol Still a Threat in Too Many American Pregnancies: StudyWomen's Cancer Screenings Plummeted During PandemicPandemic Day Care Closures Forced 600,000 U.S. Working Moms to Leave JobsNo Sign Prior COVID Infection Affects a Woman's Fertility: StudyFertility Drugs Won't Raise Breast Cancer RiskMigraines Tied to Higher Odds for Complications in PregnancyWomen, Take These Key Steps to Good Urological HealthAre Women Absorbing Toxins From Their Makeup?Race Doesn't Affect Risk for Genes That Raise Breast Cancer RiskHealthy Levels of Vitamin D May Boost Breast Cancer OutcomesHeavy Drinking Could Lower a Woman's Odds of ConceptionAHA News: Asian and Pacific Islander Women May Be at Greatest Risk for Preeclampsia ComplicationsFibroid Pain, Bleeding Is Driving Thousands of Women to the ERA Woman's Diet Might Help Her Avoid Breast CancerBreast Cancer's Spread Is More Likely in Black Women, Study FindsDrug Lynparza Could Help Fight Some Early-Stage Breast CancersAHA News: Menopause Before 40 Tied to Higher Stroke RiskHealthy Eating Lowers Pregnancy Complication RiskAortic Tears Are Even More Deadly for Women, Study FindsFDA Warns of Bogus Fertility Claims for Some SupplementsAHA News: Surprisingly Few Women May Have Good Heart Health Before PregnancyOsteoporosis Might Also Raise a Woman's Odds for Hearing LossModerate Use of Hair Relaxers Won't Raise Black Women's Cancer Risk: StudyMammography Rates Plummeted During Pandemic'Yo-Yo' Dieting May Mean Sleepless Nights for WomenGluten Doesn't Trigger 'Brain Fog' for Women Without Celiac Disease: StudyHPV Vaccination Is Lowering U.S. Cervical Cancer RatesSmoggy Air Might Raise Black Women's Odds for FibroidsAHA News: Preterm Deliveries May Pose Long-Term Stroke Risk for MothersWomen Get Help Later Than Men When Heart Attack StrikesLots of Sugary Drinks Doubles Younger Women's Colon Cancer Risk: StudyHeart Risk Factors Show Up Earlier in U.S. Black WomenBetter Access to Birth Control Boosts School Graduation RatesA Vitamin Could Be Key to Women's Pain After Knee ReplacementFreezing Tumors Could Be New Treatment for Low-Risk Breast CancersGiving Birth During the Pandemic? Facts You Need to KnowDo Your Genes Set You Up for Hot Flashes?Common Complication of Pregnancy Tied to Higher Stroke Risk Later
Questions and AnswersLinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Wellness and Personal Development
Mental Disorders

Fertility Drugs Won't Raise Breast Cancer Risk

HealthDay News
by Robert Preidt
Updated: Jun 23rd 2021

new article illustration

WEDNESDAY, June 23, 2021 (HealthDay News) -- Women battling infertility are often given medications to help them conceive, and potential side effects are always a concern. Now, research suggests use of the drugs won't raise a woman's odds for breast cancer.

Researchers at King's College London in the United Kingdom analyzed studies from 1990 to January 2020 that included 1.8 million women of all reproductive ages who underwent fertility treatment. The women were followed for an average 27 years after treatment.

Over that time, there was no significant increase in breast cancer risk among women who received fertility treatment, compared to untreated women who were infertile, according to the report published June 21 in the journal Fertility and Sterility.

"Fertility treatment can be an emotional experience," said study author Yusuf Beebeejaun, a clinical research fellow in reproductive medicine. "Patients often ask us if taking ovarian-stimulating drugs will put them at increased risk of developing cancers, including breast cancer."

Senior study author Sesh Sunkara said this study provides the evidence needed to reassure women and couples seeking fertility treatments.

"Our study showed that the use of drugs to stimulate ovaries in fertility treatment did not put women at increased risk of breast cancer," she said in a college news release.

The researchers described the long-term study as the largest ever to assess whether widely used fertility drugs increase women's cancer risk.

Fertility drugs to stimulate ovaries to release eggs have been used to treat infertility since the early 1960s. Because the drugs boost estrogen hormone production and can act on breast cells, there has been concern that this could turn the cells cancerous.

According to Katy Lindemann, a patient advocate who underwent fertility treatment, "So much of the fear, stress and anxiety associated with fertility treatment is rooted in navigating uncertainty. This study not only gives patients peace of mind at an emotional level, but also enables us to make more informed decisions about treatment risks and benefits at a rational level."

While the findings are reassuring, researchers said more long-term and detailed studies are needed to confirm these results.

More information

The U.S. National Institute of Child Health and Human Development has more on fertility treatment for women.

SOURCE: King's College London, news release, June 21, 2021